These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 20510001)
21. FHIT mRNA and protein expression in hepatocellular carcinoma. Kannangai R; Sahin F; Adegbola O; Ashfaq R; Su GH; Torbenson M Mod Pathol; 2004 Jun; 17(6):653-9. PubMed ID: 15060557 [TBL] [Abstract][Full Text] [Related]
22. [Relationship between aberrant FHIT transcripts and hepatocellular carcinoma]. Yu YC; Sun FY; Li Z; Lu SY; Teng XH Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):550-1. PubMed ID: 14552718 [TBL] [Abstract][Full Text] [Related]
23. Upregulation of the putative oncogene COTE1 contributes to human hepatocarcinogenesis through modulation of WWOX signaling. Zhang H; Tian Y; Shen J; Wang Y; Xu Y; Wang Y; Han Z; Li X Int J Oncol; 2014 Aug; 45(2):719-31. PubMed ID: 24899407 [TBL] [Abstract][Full Text] [Related]
24. ACK1 promotes hepatocellular carcinoma progression via downregulating WWOX and activating AKT signaling. Xie B; Zen Q; Wang X; He X; Xie Y; Zhang Z; Li H Int J Oncol; 2015 May; 46(5):2057-66. PubMed ID: 25738261 [TBL] [Abstract][Full Text] [Related]
25. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX. Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096 [TBL] [Abstract][Full Text] [Related]
26. Loss of fragile histidine triad protein in human hepatocellular carcinoma. Zhao P; Song X; Nin YY; Lu YL; Li XH World J Gastroenterol; 2003 Jun; 9(6):1216-9. PubMed ID: 12800227 [TBL] [Abstract][Full Text] [Related]
27. Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia. Schlott T; Ahrens K; Ruschenburg I; Reimer S; Hartmann H; Droese M Br J Cancer; 1999 Apr; 80(1-2):73-8. PubMed ID: 10389981 [TBL] [Abstract][Full Text] [Related]
28. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma. Park SW; Ludes-Meyers J; Zimonjic DB; Durkin ME; Popescu NC; Aldaz CM Br J Cancer; 2004 Aug; 91(4):753-9. PubMed ID: 15266310 [TBL] [Abstract][Full Text] [Related]
29. [Fhit expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas]. Zhang W; Zhang Y; Liu M; Huang D Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Aug; 20(15):707-10. PubMed ID: 17037022 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of Relationship between Occurrence of Liver Cancer and Methylation of Fragile Histidine Triad (FHIT) and P16 Genes. Bai Y; Shen Y; Yuan Q; Lv C; Xing Q Med Sci Monit; 2019 Feb; 25():1301-1306. PubMed ID: 30773529 [TBL] [Abstract][Full Text] [Related]
31. Roles of FHIT and WWOX fragile genes in cancer. Iliopoulos D; Guler G; Han SY; Druck T; Ottey M; McCorkell KA; Huebner K Cancer Lett; 2006 Jan; 232(1):27-36. PubMed ID: 16225988 [TBL] [Abstract][Full Text] [Related]
32. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis. Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760 [TBL] [Abstract][Full Text] [Related]
33. The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. Aderca I; Moser CD; Veerasamy M; Bani-Hani AH; Bonilla-Guerrero R; Ahmed K; Shire A; Cazanave SC; Montoya DP; Mettler TA; Burgart LJ; Nagorney DM; Thibodeau SN; Cunningham JM; Lai JP; Roberts LR J Hepatol; 2008 Sep; 49(3):373-83. PubMed ID: 18620777 [TBL] [Abstract][Full Text] [Related]
34. Common fragile genes and digestive tract cancers. Kuroki T; Tajima Y; Furui J; Kanematsu T Surg Today; 2006; 36(1):1-5. PubMed ID: 16378185 [TBL] [Abstract][Full Text] [Related]
35. Oncosuppressor proteins of fragile sites are reduced in cervical cancer. Giarnieri E; Zanesi N; Bottoni A; Alderisio M; Lukic A; Vecchione A; Ziparo V; Croce CM; Mancini R Cancer Lett; 2010 Mar; 289(1):40-5. PubMed ID: 19700237 [TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines. Roy D; Sin SH; Damania B; Dittmer DP Blood; 2011 Aug; 118(7):e32-9. PubMed ID: 21685375 [TBL] [Abstract][Full Text] [Related]
37. Alterations of the FHIT gene in human hepatocellular carcinoma. Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123 [TBL] [Abstract][Full Text] [Related]
38. Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancer. Sevinc ED; Cecener G; Ak S; Tunca B; Egeli U; Gokgoz S; Tolunay S; Tasdelen I Gene; 2016 Sep; 590(2):278-84. PubMed ID: 27236032 [TBL] [Abstract][Full Text] [Related]
39. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers. Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101 [TBL] [Abstract][Full Text] [Related]
40. Expression of B Cell-Specific Moloney Murine Leukemia Virus Integration Site 1 (BMI-1) and WW Domain-Containing Oxidoreductase (WWOX) in Liver Cancer Tissue and Normal Liver Tissue. Yu J; Hu M; Chen W; Wen Z Med Sci Monit; 2018 Sep; 24():6673-6679. PubMed ID: 30242144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]